Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 25 April at 4:30pm because of system upgrades. We expect to open them again on Friday 26 April at 8am the latest.

VINN Excellence Center Supramolecular Biomaterials - Structure dynamics and properties (SUMO) Stage 2

Reference number
Coordinator CHALMERS TEKNISKA HÖGSKOLA AKTIEBOLAG - Institutionen för kemi- och bioteknik
Funding from Vinnova SEK 21 000 000
Project duration January 2009 - December 2011
Status Completed

Purpose and goal

The vision is: Innovation based on world class research. Within the VINN Excellence Center we will design new supramolecular materials with controlled properties. The main focus is to master inherent structural properties of new supramolecular biomaterials to control properties and tailor specific functions. The program is based on powerful concepts that are of scientific and industrial interest, where the individual projects are scientifically challenging with important industrial applications. The research strategies are strongly focused but the aim is to achieve the goals by a synergistic interdisciplinary interaction that will make the Center attractive for collaboration with world leading research groups. The program is industry driven and the goal is that even the most fundamental scientific issues should have bearing on an industrial need.

Results and expected effects

The knowledge will generate a new generation of structured biomaterials with tailored mass transport properties and related functionalities. The Center will develop crucial new knowledge that can only be achieved by powerful inter¬disciplinary research in the interna¬tional front line ranging from solid state physics, visualization techniques, and mathematical modeling via colloid and surface chemistry, biopolymer technology, and materials design to pharmaceutical technology and medicine. We here also intend to direct the combined resources into a novel research area of open innovation. This research is relevant for mechanisms of commercialization, including corporate venturing, licensing and spin-off companies, and integration into core business practices. The broad applicability of the knowledge is manifested by companies in different industrial areas.

Approach and implementation

The plan and methodology is described in detail in the operational plan for Stage 2 as well as the implementation, organisation, communication and learning activities

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2009-00643

Page statistics